Evaluation der Einführung der HIV-Präexpositionsprophylaxe als Leistung der gesetzlichen Krankenversicherung (EvE‑PrEP)Daniel Schmidt, Martin Friebe, Tim Schikowski et al.|Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz|2023Cited by 16
Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET StudyFrederik Valbert, Anja Neumann, Eva Wolf et al.|Value in Health|2020Cited by 11
Socio-demographic and psycho-social determinants of HIV late presentation in Germany – results from the FindHIV studyPaul Lauscher, Eva Wolf, Nikola Hanhoff et al.|AIDS Care|2023Cited by 4